| UniProt ID | SAV1_HUMAN | |
|---|---|---|
| UniProt AC | Q9H4B6 | |
| Protein Name | Protein salvador homolog 1 | |
| Gene Name | SAV1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 383 | |
| Subcellular Localization | Nucleus . Cytoplasm . | |
| Protein Description | Regulator of STK3/MST2 and STK4/MST1 in the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. SAV1 is required for STK3/MST2 and STK4/MST1 activation and promotes cell-cycle exit and terminal differentiation in developing epithelial tissues. Plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with STK3/MST2, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation.. | |
| Protein Sequence | MLSRKKTKNEVSKPAEVQGKYVKKETSPLLRNLMPSFIRHGPTIPRRTDICLPDSSPNAFSTSGDVVSRNQSFLRTPIQRTPHEIMRRESNRLSAPSYLARSLADVPREYGSSQSFVTEVSFAVENGDSGSRYYYSDNFFDGQRKRPLGDRAHEDYRYYEYNHDLFQRMPQNQGRHASGIGRVAATSLGNLTNHGSEDLPLPPGWSVDWTMRGRKYYIDHNTNTTHWSHPLEREGLPPGWERVESSEFGTYYVDHTNKKAQYRHPCAPSVPRYDQPPPVTYQPQQTERNQSLLVPANPYHTAEIPDWLQVYARAPVKYDHILKWELFQLADLDTYQGMLKLLFMKELEQIVKMYEAYRQALLTELENRKQRQQWYAQQHGKNF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 26 | Phosphorylation | GKYVKKETSPLLRNL CCCCCCCCCHHHHHH | 44.52 | 30266825 | |
| 27 | Phosphorylation | KYVKKETSPLLRNLM CCCCCCCCHHHHHHH | 18.03 | 30266825 | |
| 36 | Phosphorylation | LLRNLMPSFIRHGPT HHHHHHHHHHHHCCC | 21.24 | 21944251 | |
| 55 | Phosphorylation | TDICLPDSSPNAFST CCEECCCCCCCCCCC | 45.84 | 30576142 | |
| 56 | Phosphorylation | DICLPDSSPNAFSTS CEECCCCCCCCCCCC | 29.56 | 21815630 | |
| 61 | Phosphorylation | DSSPNAFSTSGDVVS CCCCCCCCCCCCHHH | 21.18 | 23898821 | |
| 62 | Phosphorylation | SSPNAFSTSGDVVSR CCCCCCCCCCCHHHC | 30.21 | 30576142 | |
| 72 | Phosphorylation | DVVSRNQSFLRTPIQ CHHHCCHHHCCCCCC | 29.78 | 21712546 | |
| 75 | Methylation | SRNQSFLRTPIQRTP HCCHHHCCCCCCCCH | 36.12 | 54559095 | |
| 76 | Phosphorylation | RNQSFLRTPIQRTPH CCHHHCCCCCCCCHH | 27.22 | 29214152 | |
| 81 | Phosphorylation | LRTPIQRTPHEIMRR CCCCCCCCHHHHHHH | 16.78 | 28555341 | |
| 90 | Phosphorylation | HEIMRRESNRLSAPS HHHHHHHHCCCCHHH | 25.99 | 21712546 | |
| 94 | Phosphorylation | RRESNRLSAPSYLAR HHHHCCCCHHHHHHH | 34.59 | 30266825 | |
| 97 | Phosphorylation | SNRLSAPSYLARSLA HCCCCHHHHHHHHHH | 32.28 | 30266825 | |
| 98 | Phosphorylation | NRLSAPSYLARSLAD CCCCHHHHHHHHHHC | 11.88 | 23403867 | |
| 102 | Phosphorylation | APSYLARSLADVPRE HHHHHHHHHHCCCHH | 23.46 | 28060719 | |
| 112 | Phosphorylation | DVPREYGSSQSFVTE CCCHHHCCCCCEEEE | 25.05 | 27251275 | |
| 113 | Phosphorylation | VPREYGSSQSFVTEV CCHHHCCCCCEEEEE | 26.02 | 27251275 | |
| 133 | Phosphorylation | NGDSGSRYYYSDNFF CCCCCCEEEECCCCC | 14.41 | 29978859 | |
| 134 | Phosphorylation | GDSGSRYYYSDNFFD CCCCCEEEECCCCCC | 8.72 | 29978859 | |
| 135 | Phosphorylation | DSGSRYYYSDNFFDG CCCCEEEECCCCCCC | 10.70 | 29978859 | |
| 136 | Phosphorylation | SGSRYYYSDNFFDGQ CCCEEEECCCCCCCC | 15.23 | 22617229 | |
| 156 | Phosphorylation | GDRAHEDYRYYEYNH CCCCCHHHHHHHCCC | 9.49 | 27642862 | |
| 158 | Phosphorylation | RAHEDYRYYEYNHDL CCCHHHHHHHCCCCH | 8.40 | 29978859 | |
| 159 | Phosphorylation | AHEDYRYYEYNHDLF CCHHHHHHHCCCCHH | 11.70 | 29978859 | |
| 161 | Phosphorylation | EDYRYYEYNHDLFQR HHHHHHHCCCCHHHH | 11.15 | 27642862 | |
| 168 | Methylation | YNHDLFQRMPQNQGR CCCCHHHHCCCCCCC | 31.26 | 115493375 | |
| 186 | Phosphorylation | GIGRVAATSLGNLTN CHHHHHHHHHCCCCC | 18.10 | 23090842 | |
| 187 | Phosphorylation | IGRVAATSLGNLTNH HHHHHHHHHCCCCCC | 29.56 | 23090842 | |
| 192 | Phosphorylation | ATSLGNLTNHGSEDL HHHHCCCCCCCCCCC | 29.21 | 23090842 | |
| 196 | Phosphorylation | GNLTNHGSEDLPLPP CCCCCCCCCCCCCCC | 22.01 | 23090842 | |
| 206 | Phosphorylation | LPLPPGWSVDWTMRG CCCCCCCEEEEEECC | 19.00 | 28270605 | |
| 210 | Phosphorylation | PGWSVDWTMRGRKYY CCCEEEEEECCEEEE | 7.79 | 22817900 | |
| 245 | Phosphorylation | PGWERVESSEFGTYY CCCEEEHHHCCEEEE | 32.10 | 30576142 | |
| 246 | Phosphorylation | GWERVESSEFGTYYV CCEEEHHHCCEEEEE | 24.36 | 30576142 | |
| 250 | Phosphorylation | VESSEFGTYYVDHTN EHHHCCEEEEEECCC | 19.59 | 25332170 | |
| 251 | Phosphorylation | ESSEFGTYYVDHTNK HHHCCEEEEEECCCC | 11.23 | 30576142 | |
| 256 | Phosphorylation | GTYYVDHTNKKAQYR EEEEEECCCCEEECC | 44.24 | 25332170 | |
| 258 | Ubiquitination | YYVDHTNKKAQYRHP EEEECCCCEEECCCC | 51.12 | - | |
| 262 | Phosphorylation | HTNKKAQYRHPCAPS CCCCEEECCCCCCCC | 18.75 | 25332170 | |
| 269 | Phosphorylation | YRHPCAPSVPRYDQP CCCCCCCCCCCCCCC | 26.65 | 21944251 | |
| 281 | Phosphorylation | DQPPPVTYQPQQTER CCCCCCCCCCCCCCC | 20.59 | 27642862 | |
| 357 | Phosphorylation | IVKMYEAYRQALLTE HHHHHHHHHHHHHHH | 7.42 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 26 | T | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| 27 | S | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| 36 | S | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| 269 | S | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| - | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:25692647 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SAV1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SAV1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-26; SER-27; SER-56;SER-90; SER-94; SER-136; THR-186 AND THR-210, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-26, AND MASSSPECTROMETRY. | |